Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jacqueline McBride"'
Autor:
Priscilla Horn, Nimer Assy, Jacqueline McBride, Jeremy J. Lim, Rong Deng, Anna Nilsson, Joshua Galanter, Jorge A. Tavel, Allen Nguyen, Mauricio Maia, Melicent C. Peck, Xiaoying Yang, Aide Castro, Elizabeth M. Newton, Michael Silverman, Tom Chu, Chloe Li, Priya Kulkarni
Publikováno v:
Antimicrobial Agents and Chemotherapy
For patients hospitalized with severe influenza A virus infection, morbidity and mortality remain high. MHAA4549A, a human monoclonal antibody targeting the influenza A virus hemagglutinin stalk, has demonstrated pharmacological activity in animal st
Autor:
Jacqueline McBride, Jorge A. Tavel, Mauricio Maia, X. Charlene Liao, William D. Hanley, Rong Deng, Yehong Wang, Tracy Burgess
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
RG7667, a novel combination of two anticytomegalovirus (anti-CMV) monoclonal IgG1 antibodies (MCMV5322A and MCMV3068A), was designed to block CMV entry into host cells. It was developed as a potential therapy for preventing CMV infection and disease
Autor:
Hosnieh Fathi, Haiyin Chen-Harris, Carrie M. Rosenberger, Tracy Burgess, Rob Lambkin-Williams, Denise Nazzal, Elizabeth M. Newton, Jeffrey M. Harris, Dimitri Fillos, Jorge A. Tavel, Mauricio Maia, Daniel Sheinson, Jacqueline McBride, Maikke B. Ohlson, Rong Deng, Michael A. Derby, Priscilla Horn, Jeremy J. Lim, Omer Siddiqui
Publikováno v:
Antimicrobial agents and chemotherapy. 62(1)
Autor:
Carrie M. Rosenberger, Dimitri Fillos, Maikke B. Ohlson, Jacqueline McBride, Tracy Burgess, Jeffrey M. Harris, Hosnieh Fathi, Jeremy J. Lim, Rob Lambkin-Williams, Michael A. Derby, Omer Siddiqui, Daniel Sheinson, Rong Deng, Jorge A. Tavel, Haiyin Chen-Harris, Priscilla Horn, Mauricio Maia, Denise Nazzal, Elizabeth M. Newton
Publikováno v:
Antimicrobial Agents and Chemotherapy. 61
MHAA4549A, a human monoclonal antibody targeting the hemagglutinin stalk region of influenza A virus (IAV), is being developed as a therapeutic for patients hospitalized with severe IAV infection. The safety and efficacy of MHAA4549A were assessed in